PRECISION OPTICS CORP INC
POCINASDAQTrading Snapshot
- Day Range
- $4.23 – $4.35
- 52-Week Range
- $3.55 – $6.15
- Volume
- $3.37B
- Avg Volume
- $3.12B
- Shares Outstanding
- 10.9M
- Next Earnings
- Nov 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $9M
- P/E Ratio
- -10.5
- P/S Ratio
- 0.0x
- EPS (TTM)
- $0.00
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +21.5%
Why Investors Own POCI
- ✓High-growth profile — revenue up -6.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 40% gross margin and 10% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PRECISION OPTICS CORP INC
POCI
StockOtter · stockotter.spaceAbout PRECISION OPTICS CORP INC
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference
LITTLETON, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries
Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript
Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript
Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Conference Call Scheduled for Today, September 28, 2026, at 5:00 p.m. ET Conference Call Scheduled for Today, September 28, 2026, at 5:00 p.m. ET
Reviewing IceCure Medical (NASDAQ:ICCM) & Precision Optics (NASDAQ:POCI)
Precision Optics (NASDAQ: POCI - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on t
Precision Optics Schedules Fourth Quarter and Fiscal Year 2026 Conference Call for September 28, 2026
LITTLETON, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aero
Precision Optics Announces Initial Engineering Order from New Satellite Optical Communications Customer
LITTLETON, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aero